Optimind Pharma Corp.
Optimind Pharma Corp.
CSE Index:
Currency:
Optimind Pharma Corp. specializes in prescribing medical cannabis and other alternative treatments for various medical ailments. The Issuer prides itself on providing quality education and health care to patients. The Issuer is also an emerging provider of psychedelic therapies at its clinic, helping people suffering from PTSD, anxiety, depression, and other mental illnesses and disabilities by providing ketamine assisted treatment and other psychedelic enhanced psychotherapy modalities.
Optimind Pharma Corp. (OMND)
SEDAR Information
Company Info
Address
77 King Street West - Suite 3000
Toronto, ON M5K 1G8
CanadaPhone
(647) 891-9379Email
[email protected]Website
https://www.optimindpharma.comListing date
Thursday, August 4, 2022Transfer Agent
Computershare Investor Services Inc.Capitalization
Issued & Outstanding:
98,091,991Reserved for Issuance:
9,956,000Company Officers
Tom Sipos, President and CEO
Rakesh Malhotra, CFO and Secretary
Dr. Mike Hart, Chief Operating Officer
Bulletins
03/08/2022
2022-0803 - New Listing - Optimind Pharma Corp. (OMND)
le 3 août/August 2022
The common shares of Optimind Pharma Corp. have been approved for listing on the CSE.
Listing and disclosure documents will be available at www.thecse.com on the trading date.
